Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    21777974 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: Reverse hybrid therapy;   Drug: Standard triple therapy
2 Completed S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori)
Condition: Helicobacter Pylori Infection
Interventions: Drug: PACx14;   Drug: PACMx5;   Drug: PAx5/PCMx5
3 Active, not recruiting European Registry on the Management of Helicobacter Pylori Infection
Condition: H. Pylori Infection
Intervention:

Indicates status has not been verified in more than two years